Trial Profile

A Phase IB/II Study of Sunitinib in Combination With Neoadjuvant Radiation in Patients With Resectable Soft-Tissue Sarcoma.

Status: Completed

Phase of Trial: Phase I/II

Latest Information Update: 27 Feb 2017

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Sunitinib (Primary)
Indications Soft tissue sarcoma
Focus Adverse reactions

Most Recent Events

16 Oct 2014 Status changed from active, no longer recruiting to completed according to results published in the British Journal of Cancer.
01 Jan 2013 Status changed from recruiting to active, no longer recruiting according to results published in the British Journal of Cancer.
08 May 2009 Additional trial identifiers (ACTRN12608000474358, 083144, 08/05) identified as reported by Australian New Zealand Clinical Trials Registry record.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com